Skip to main navigation Skip to search Skip to main content

A 52 Week, Randomized, Double-Blinded, Placeo-Controlled, Multi-Center, Parallel-Group Study of the Long Term Efficacy, Tolerablity, and Safety...

Project: Research

Project Details

StatusFinished
Effective start/end date01/1/07 → 03/31/10

Funding

  • Novartis Pharmaceuticals Corporation: $12,703.31